PortalPublikationenComorbidity of schizophrenia and galactosemia: effective clo...

Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain.

Standard

Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain. / Haasen, Christian; Lambert, Martin; Yagdiran, Oktay; Karow, Anne; Krausz, Michael; Naber, Dieter.

in: INT CLIN PSYCHOPHARM, Jahrgang 18, Nr. 2, 2, 2003, S. 113-115.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Haasen, C, Lambert, M, Yagdiran, O, Karow, A, Krausz, M & Naber, D 2003, 'Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain.', INT CLIN PSYCHOPHARM, Jg. 18, Nr. 2, 2, S. 113-115. <http://www.ncbi.nlm.nih.gov/pubmed/12598824?dopt=Citation>

APA

Haasen, C., Lambert, M., Yagdiran, O., Karow, A., Krausz, M., & Naber, D. (2003). Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain. INT CLIN PSYCHOPHARM, 18(2), 113-115. [2]. http://www.ncbi.nlm.nih.gov/pubmed/12598824?dopt=Citation

Vancouver

Haasen C, Lambert M, Yagdiran O, Karow A, Krausz M, Naber D. Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain. INT CLIN PSYCHOPHARM. 2003;18(2):113-115. 2.

Bibtex

@article{eea2eacb889a411ba1810f603bdc67da,
title = "Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain.",
abstract = "Weight gain with atypical antipsychotics such as clozapine has been hypothesized to have a multifactorial genesis. Beside changes in neurotransmitter systems caused by antipsychotic-induced receptor blockade, hormonal changes and other neuroleptic side-effects (sedation, reduced activity, reduced basal metabolic rate, dry mouth) are also discussed. Our unique case report of a patient with comorbid galactosemia and schizophrenia is an interesting example of weight gain being a positive side-effect of clozapine, not necessarily associated with increased appetite and higher caloric intake.",
author = "Christian Haasen and Martin Lambert and Oktay Yagdiran and Anne Karow and Michael Krausz and Dieter Naber",
year = "2003",
language = "Deutsch",
volume = "18",
pages = "113--115",
journal = "INT CLIN PSYCHOPHARM",
issn = "0268-1315",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain.

AU - Haasen, Christian

AU - Lambert, Martin

AU - Yagdiran, Oktay

AU - Karow, Anne

AU - Krausz, Michael

AU - Naber, Dieter

PY - 2003

Y1 - 2003

N2 - Weight gain with atypical antipsychotics such as clozapine has been hypothesized to have a multifactorial genesis. Beside changes in neurotransmitter systems caused by antipsychotic-induced receptor blockade, hormonal changes and other neuroleptic side-effects (sedation, reduced activity, reduced basal metabolic rate, dry mouth) are also discussed. Our unique case report of a patient with comorbid galactosemia and schizophrenia is an interesting example of weight gain being a positive side-effect of clozapine, not necessarily associated with increased appetite and higher caloric intake.

AB - Weight gain with atypical antipsychotics such as clozapine has been hypothesized to have a multifactorial genesis. Beside changes in neurotransmitter systems caused by antipsychotic-induced receptor blockade, hormonal changes and other neuroleptic side-effects (sedation, reduced activity, reduced basal metabolic rate, dry mouth) are also discussed. Our unique case report of a patient with comorbid galactosemia and schizophrenia is an interesting example of weight gain being a positive side-effect of clozapine, not necessarily associated with increased appetite and higher caloric intake.

M3 - SCORING: Zeitschriftenaufsatz

VL - 18

SP - 113

EP - 115

JO - INT CLIN PSYCHOPHARM

JF - INT CLIN PSYCHOPHARM

SN - 0268-1315

IS - 2

M1 - 2

ER -